Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B
Clinical trial NCT05164471 · TERMINATED
Trial details
- NCT number
- NCT05164471
- Sponsor
- Spur Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2023-05-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.